Author:
Zapata Miana R,Pandit Trupti,Goyal Lokesh,Ajmera Kunal,Chourasia Prabal,Pandit Ramesh
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults;Ludvigsson JF;Acta Paediatr,2020
2. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). (2020). Accessed. October 15, 2022: https://emergency.cdc.gov/han/2020/han00432.asp.
3. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation;Yousaf AR;Lancet Child Adolesc Health,2022
4. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years - United States, July-December 2021;Zambrano LD;MMWR Morb Mortal Wkly Rep,2022
5. Multisystem inflammatory syndrome in children (MIS-C) interim guidance. (2023). Accessed. March 1, 2023: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-sy....